1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,555 | 0,580 | 11:52 | |
| 0,555 | 0,580 | 11:52 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| YIDU TECH Aktie jetzt für 0€ handeln | |||||
| 11.12. | YIDU TECH (02158): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 03.12. | YIDU TECH (02158): GRANT OF SHARE AWARDS | - | HKEx | ||
| 03.12. | YIDU TECH (02158): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 27.11. | YIDU TECH Interim Loss Narrows to RMB14.602M | 1 | AASTOCKS | ||
| 27.11. | YIDU TECH (02158): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025 | 1 | HKEx | ||
| 17.11. | YIDU TECH (02158): NOTICE OF BOARD MEETING | 1 | HKEx | ||
| 23.10. | YIDU TECH (02158): VOLUNTARY ANNOUNCEMENT - TOTAL RETURN SWAP | - | HKEx | ||
| 22.10. | YIDU TECH (02158): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 17.10. | YIDU TECH (02158): NEXT DAY DISCLOSURE RETURNS | 1 | HKEx | ||
| 13.10. | YIDU TECH (02158): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 26.09. | YIDU TECH (02158): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 23.09. | YIDU TECH (02158): VOLUNTARY ANNOUNCEMENT - SUCCESSFUL BIDDING FOR PHASE III CLINICAL STUDY PROJECT OF RECOMBINANT HUMAN NEUROGENESIS FACTOR (SMR001) ... | 1 | HKEx | ||
| 29.08. | YIDU TECH (02158): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, AUGUST 29, 2025 | - | HKEx | ||
| 25.07. | YIDU TECH (02158): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED HOLDERS | 1 | HKEx | ||
| 25.07. | YIDU TECH (02158): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS | 1 | HKEx | ||
| 25.07. | YIDU TECH (02158): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, AUGUST 29, 2025 | - | HKEx | ||
| 25.07. | YIDU TECH (02158): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 25.07. | YIDU TECH (02158): NOTICE OF ANNUAL GENERAL MEETING AND PROPOSALS FOR (1) GENERAL MANDATES TO ISSUE SHARES AND SELL AND/OR TRANSFER TREASURY SHARES AND ... | 1 | HKEx | ||
| 25.07. | YIDU TECH (02158): 2025 ANNUAL REPORT | 1 | HKEx | ||
| 30.06. | YIDU TECH (02158): GRANT OF SHARE AWARDS | 2 | HKEx |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDLINE | 40,450 | 0,00 % | Aktien New York: Nasdaq schwach nach starkem Jahr - Medline-Börsengang im Blick | NEW YORK (dpa-AFX) - Die US-Börsen haben am Mittwoch erneut nachgegeben. Die Wall Street und vor allem die technologielastige Nasdaq zollten ihrem starken Lauf im Jahr 2025 weiter Tribut. Sorgen über... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,590 | 0,00 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| HEARTBEAM | 3,060 | 0,00 % | Heartbeam stock is a buy, this analyst says | ||
| PROGYNY | 26,010 | 0,00 % | Progyny, Inc. - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 20,550 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,220 | -0,20 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,460 | -0,40 % | Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers | DJ Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers
DOW JONES--Moody's hat Siemens Healthineers die Bonitätsbewertung A3 gegeben, was als sichere Anlage gilt. Der Ausblick ist... ► Artikel lesen | |
| BETA BIONICS | 29,200 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 135,46 | 0,00 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| PROCEPT BIOROBOTICS | 33,780 | 0,00 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| FRESENIUS | 47,830 | +0,10 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 53,60 Euro auf "Overweight" belassen. Die Veranstaltung mit dem Biopharma-Management der Bad... ► Artikel lesen | |
| RXSIGHT | 12,620 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
| NUTEX HEALTH | 159,17 | 0,00 % | Nutex Health, Inc.: Nutex Health Responds To Short Seller Report | HOUSTON, Nov. 26, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), is aware of a short seller report issued on November... ► Artikel lesen | |
| CLEARPOINT NEURO | 13,550 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,915 | +0,51 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
Das Unternehmen YIDU TECH INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,550 Euro und damit +2,80 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu YIDU TECH INC finden Sie auf Wallstreet Online.